Epigenetic changes in histone acetylation underpin resistance to the topoisomerase I inhibitor irinotecan.

MLA

Meisenberg, Cornelia, et al. “Epigenetic Changes in Histone Acetylation Underpin Resistance to the Topoisomerase I Inhibitor Irinotecan.” Nucleic Acids Research, vol. 45, no. 3, Feb. 2017, pp. 1159–76. EBSCOhost, https://doi.org/10.1093/nar/gkw1026.

APA

Meisenberg, C., Ashour, M. E., El-Shafie, L., Liao, C., Hodgson, A., Pilborough, A., Khurram, S. A., Downs, J. A., Ward, S. E., & El-Khamisy, S. F. (2017). Epigenetic changes in histone acetylation underpin resistance to the topoisomerase I inhibitor irinotecan. Nucleic Acids Research, 45(3), 1159–1176. https://doi.org/10.1093/nar/gkw1026

Chicago

Meisenberg, Cornelia, Mohamed E Ashour, Lamia El-Shafie, Chunyan Liao, Adam Hodgson, Alice Pilborough, Syed A Khurram, Jessica A Downs, Simon E Ward, and Sherif F El-Khamisy. 2017. “Epigenetic Changes in Histone Acetylation Underpin Resistance to the Topoisomerase I Inhibitor Irinotecan.” Nucleic Acids Research 45 (3): 1159–76. doi:10.1093/nar/gkw1026.